Home / Congress Presentations / C3G and IC-MPGN / International Society for Pharmacoeconomics and Outcomes Research Europe (ISPOR EU) 2024
Landing
International Society for Pharmacoeconomics and Outcomes Research Europe (ISPOR EU) 2024
Real-world survey on treatment pathways and patterns for patients with primary Immune Complex Membranoproliferative Glomerulonephritis
Real-world survey on healthcare resource utilisation and physician-reported burden in patients with primary Immune Complex Membranoproliferative Glomerulonephritis
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.